Outcome of childhood acute lymphoblastic leukemia treated using the thai national protocols

by Panya Seksarn, Surapon Wiangnon, Gavivann Veerakul, Thirachit Chotsampancharoen, Somjai Kanjanapongkul, Su On Chainansamit
Published 2018

Late effects in survivors of childhood acute lymphoblastic leukemia: A study from Thai Pediatric Oncology Group

by Pakakasama S., Veerakul G., Sosothikul D., Chainansamit S., Laosombat V., Thanarattanakorn P., Lumkul R., Wiangnon S., Wangruangsathit S., Narkbunnam N., Kanjanapongkul S.
Published 2017

Late effects in survivors of childhood acute lymphoblastic leukemia: A study from Thai Pediatric Oncology Group

by Samart Pakakasama, Gavivann Veerakul, Darin Sosothikul, Su On Chainansamit, Vichai Laosombat, Pattra Thanarattanakorn, Rachata Lumkul, Surapon Wiangnon, Somporn Wangruangsathit, Nattee Narkbunnam, Somjai Kanjanapongkul
Published 2018

Late effects in survivors of childhood acute lymphoblastic leukemia: A study from Thai Pediatric Oncology Group

by Samart Pakakasama, Gavivann Veerakul, Darin Sosothikul, Su On Chainansamit, Vichai Laosombat, Pattra Thanarattanakorn, Rachata Lumkul, Surapon Wiangnon, Somporn Wangruangsathit, Nattee Narkbunnam, Somjai Kanjanapongkul
Published 2018

Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations

by Kanyarat Khaeso, Sariya Udayachalerm, Patcharee Komvilaisak, Su On Chainansamit, Kunanya Suwannaying, Napat Laoaroon, Pitchayanan Kuwatjanakul, Nontaya Nakkam, Chonlaphat Sukasem, Apichaya Puangpetch, Wichittra Tassaneeyakul, Nathorn Chaiyakunapruk
Published 2022

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: A...

by Piya Rujkijyanont, Apichat Photia, Chanchai Traivaree, Chalinee Monsereenusorn, Usanarat Anurathapan, Panya Seksarn, Darintr Sosothikul, Piti Techavichit, Kleebsabai Sanpakit, Kamon Phuakpet, Surapon Wiangnon, Thirachit Chotsampancharoen, Su On Chainansamit, Somjai Kanjanapongkul, Arunotai Meekaewkunchorn, Suradej Hongeng
Published 2020

Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group

by Kunanya Suwannaying, Chalinee Monsereenusorn, Piya Rujkijyanont, Piti Techavichit, Kamon Phuakpet, Pongpak Pongphitcha, Su on Chainansamit, Thirachit Chotsampancharoen, Angkana Winaichatsak, Chanchai Traivaree, Lalita Sathitsamitphong, Somjai Kanjanapongkul, Patcharee Komvilaisak, Kleebsabai Sanpakit, Apichat Photia, Panya Seksarn, Surapon Wiangnon, Suradej Hongeng
Published 2022

Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes

by Bunchoo Pongtanakul, Nongnuch Sirachainan, Pacharapan Surapolchai, Pimlak Charoenkwan, Worawut Choeyprasert, Patcharee Komwilaisak, Su on Chainansamit, Nittaya Witsanuyothin, Yujinda Lertrakul, Piya Rujkijyanont, Somjai Kanjanapongkul, Darintr Sosothikul, Kleebsabai Sanpakit, Thirachit Chotsampancharoen, Somporn Wangruangsathit, Nintita Sripaiboonkij Thokanit, Sommaphun Tabjareon, Suradej Hongeng
Published 2020

Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes

by Bunchoo Pongtanakul, Nongnuch Sirachainan, Pacharapan Surapolchai, Pimlak Charoenkwan, Worawut Choeyprasert, Patcharee Komwilaisak, Su on Chainansamit, Nittaya Witsanuyothin, Yujinda Lertrakul, Piya Rujkijyanont, Somjai Kanjanapongkul, Darintr Sosothikul, Kleebsabai Sanpakit, Thirachit Chotsampancharoen, Somporn Wangruangsathit, Nintita Sripaiboonkij Thokanit, Sommaphun Tabjareon, Suradej Hongeng
Published 2020